Oral drug normalizes blood potassium in 98 percent of kidney patients

30 marzo 2015

A medication called ZS-9 normalized potassium in the blood of 98 percent of chronic kidney disease patients treated for hyperkalemia. Hyperkalemia is high potassium in the blood, and may occur as a side effect of taking kidney disease medications called Renin Angiotensin Aldosterone System inhibitors. Hyperkalemia increases the risk of cardiac arrhythmias.